290 Binney Street
290 Binney Street
is a new commercial development consisting of 425,333 SF of lab and office space. Once complete, the building will be occupied by AstraZeneca.
The CRA welcomes another research headquarters to Kendall Square. Construction of 290 Binney Street began in 2023 and has progressed substantially thanks to an innovative method called “up-down construction,” where basement floors are built downward as excavation progresses and the upward structure starts simultaneously. The building exterior has been completed, and the façade now bears the trademark metal latticework that gives the project its distinct look. The building’s interior has continued to progress, including work on the two-story lobby and other tenant spaces. The AstraZeneca logo is also now visible on the building’s northwest facade.
Construction of the 290 Binney Street is expected to be completed in summer, 2026.
Review and Approval Documents:
290 Binney Street 2 Way Drive Aisle Presentation (August 27, 2024)
290 Binney Street Commercial (Approved April 19, 2022)
IDCP Amendment II Master Plan - (Approved January 14, 2022)
Massachusetts Environmental Policy Act - Certificate of Approval (November 2021)
This Project is Part of the IDCP (Infill Development Concept Plan). See other projects:
-
Project Partners:
BXP
Design Architect:
Pickard Chilton
Landscape Architect:
Lemon Brooke
General Contractor:
Turner Construction
Year Started:
2019 -
Joel Smith, ext 14, jsmith@cambridgeredevelopment.org
This Project In the News
